Tuesday, November 17, 2026
Tags. MediTech

Tags:. MediTech

Veterinary Medical Startup "Happy Cat Doggie" Completes Fundraising! Tackling cat FIP and other unmet needs

Happy Cat and Dog, a veterinary drug research and development company, has recently completed a seed round of financing with multiple venture capital funds as underwriters. The company intends to fully pursue research and development and build a business foundation in the area of veterinary diseases for which effective treatment options are still limited, such as feline infectious peritonitis.

Japan's First Remote End-of-Life Care Service Promotes End-of-Life Care DX! Reducing Physicians' Burden and Ensuring Patients' Dignity at the End of Life

ShareMedical announced the launch of Japan's first "remote end-of-life care" service combining its digital listening device "Nextate" and the medical chat service "Mediline Workplace.

Metagen Therapeutics raises a total of 2.32 billion yen in Series B! Accelerating Gut Bacteria Medicine

Metagen Therapeutics, a company that promotes medical and drug discovery based on gut bacteria research, completed a Series B round of financing totaling 2.32 billion yen from July to September 2025, bringing in seven existing investors and four new investors, including a global investor. This brings the company's cumulative total raised to 4.26 billion yen. With this financing, the company plans to further accelerate the development of its oral FMT drug for ulcerative colitis, which is currently under development, as well as to strengthen its organizational structure and expand its human resources in order to expand its business.

Mitsubishi Research Institute, Inc. and Astellas Pharma Inc. partner in drug discovery startup support program! Creating Innovative Medical Solutions

Mitsubishi Research Institute (MRI) and Astellas Pharma Inc. have signed a letter of intent to collaborate on drug discovery startup support services in the "Medical Venture Total Support Project" commissioned by the Ministry of Health, Labor and Welfare (MHLW)!

NVIDIA Partners with Industry Leaders! Transforming the Healthcare and Life Sciences Industry

[Open Innovation News] NVIDIA's new partnership to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, enhancing genomic research, and pioneering advanced healthcare services through the use of agentic and generative AI announced today!

MedTech Angels Season 4, an acceleration program specializing in medical devices, selects selected companies!

PremoPartner, an incubator for medical device development, is running MedTech Angels Season 4, a medical device-specific accelerator program. We are pleased to announce that this year's participants have been selected from a large number of applicants and the accelerator program has started!

Fujitsu, together with pharmaceutical companies and medical institutions, creates an ecosystem to accelerate the digitalization of clinical trials! Eliminating Drug Losses in Japan

Fujitsu Uvance, a business model for solving social issues through cross-industry collaboration, is a business model that aims to improve people's wellbeing. In order to solve the problem of drug loss in Japan, Fujitsu Uvance will work with pharmaceutical companies and medical institutions to build a new ecosystem that utilizes medical data in the clinical trial field and attract international joint clinical trials to Japan!

Open Innovation|Creating greater value through collaboration, Sanshin Open Innovation

Sanshin Pharmaceutical, which has expanded and relocated its research center to Magok-dong, Gangseo-gu, Seoul, to expand its advanced research facilities and strengthen its R&D infrastructure based on its sustained R&D investment, is holding an accelerator program. We are looking for startups who can collaborate and grow together with us as we make the leap to become a global pharmaceutical company. The deadline for applications is August 18.

Gericle Wins Grand Prize at CFS Open Innovation Pitch 2024! Aiming for Medical Innovation with Tetragel

[Open Innovation News] Gericle, a bio-venture company from the University of Tokyo that aims for medical innovation using tetragel, won the grand prize at CFS Open Innovation Pitch 2024, a pitch contest organized by CF Startup Partners!

Enamine and SyntheticGestalt to develop AI-based models to facilitate drug discovery!

SyntheticGestalt and Enamine will use the 38 billion compounds in the REAL database as a training dataset to develop pre-training and generative AI models to discover synthesizable and drug-like candidate compounds!

PICKUP.